메뉴 건너뛰기




Volumn 93, Issue 13, 2001, Pages 979-989

National institutes of health consensus development conference statement: Adjuvant therapy for breast cancer, November 1-3, 2000

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANTHRACYCLINE; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GONADORELIN AGONIST; GOSERELIN; HORMONE RECEPTOR; PACLITAXEL; RALOXIFENE; RECEPTOR PROTEIN; TAMOXIFEN; TAXANE DERIVATIVE;

EID: 0035806484     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.13.979     Document Type: Article
Times cited : (697)

References (88)
  • 3
    • 10144258654 scopus 로고    scopus 로고
    • Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology
    • American Society of Clinical Oncology.
    • (1996) J Clin Oncol , vol.14 , pp. 2843-2877
  • 4
    • 0002409517 scopus 로고    scopus 로고
    • Results from a randomized adjuvant breast cancer study with high dose chemotherapy with CTCb supported by autologous bone marrow stem cells versus dose escalated and tailored FEC therapy
    • [abstract]
    • (1999) Proc ASCO , vol.18 , pp. 3
    • Bergh, J.1
  • 5
    • 0003344884 scopus 로고    scopus 로고
    • Randomised, controlled trial of high dose chemotherapy versus standard dose chemotherapy for high risk, surgically treated, primary breast cancer
    • [abstract]
    • (1999) Proc ASCO , vol.18 , pp. 4
    • Bezwoda, W.R.1
  • 8
    • 0033428408 scopus 로고    scopus 로고
    • The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute Black-White Cancer Survival Study
    • (1999) Ethn Dis , vol.9 , pp. 111-125
    • Breen, N.1    Wesley, M.N.2    Merrill, R.M.3    Johnson, K.4
  • 17
    • 0034690745 scopus 로고    scopus 로고
    • Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials
    • Early Breast Cancer Trialists' Collaborative Group.
    • (2000) Lancet , vol.355 , pp. 1757-1770
  • 18
    • 0032537396 scopus 로고    scopus 로고
    • Tamoxifen for early breast cancer: An overview of the randomised trials
    • Early Breast Cancer Trialists' Collaborative Group.
    • (1998) Lancet , vol.351 , pp. 1451-1467
  • 19
    • 0032547564 scopus 로고    scopus 로고
    • Polychemotherapy for early breast cancer: An overview of the randomized trials
    • Early Breast Cancer Trialists' Collaborative Group.
    • (1998) Lancet , vol.352 , pp. 930-942
  • 20
    • 0029806829 scopus 로고    scopus 로고
    • Ovarian ablation in early breast cancer: Overview of the randomised trials
    • Early Breast Cancer Trialists' Collaborative Group.
    • (1996) Lancet , vol.348 , pp. 1189-1196
  • 21
    • 0028791012 scopus 로고
    • Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials
    • Early Breast Cancer Trialists' Collaborative Group.
    • (1995) N Engl J Med , vol.333 , pp. 1444-1455
  • 32
    • 8944231160 scopus 로고    scopus 로고
    • Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: Eight-year results from National Surgical Adjuvant Breast and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil
    • (1996) J Clin Oncol , vol.14 , pp. 1982-1992
    • Fisher, B.1    Dignam, J.2    Mamounas, E.P.3    Costantino, J.P.4    Wickerham, D.L.5    Redmond, C.6
  • 44
    • 0032750091 scopus 로고    scopus 로고
    • High-dose chemotherapy for primary breast cancer: Facts versus anecdotes
    • (1999) J Clin Oncol , vol.17 , Issue.SUPPL. 11 , pp. 25-29
    • Hortobagyi, G.N.1
  • 53
    • 0030805625 scopus 로고    scopus 로고
    • Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel
    • NSABP Protocol B-27. (Huntingt)
    • (1997) Oncology , vol.11 , Issue.6 SUPPL. 6 , pp. 37-40
    • Mamounas, E.P.1
  • 56
    • 0004497294 scopus 로고
    • Treatment of early stage breast cancer
    • National Institutes of Health Consensus Development Panel.
    • (1992) J Natl Cancer Inst Monogr , vol.11 , pp. 137-142
  • 57
    • 0022466504 scopus 로고
    • National Institutes of Health Consensus Development Conference Statement: Adjuvant Chemotherapy for Breast Cancer
    • September 9-11, 1985
    • (1986) CA Cancer J Clin , vol.36 , pp. 42-47
  • 72
    • 0027263487 scopus 로고
    • Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: The Scottish trial
    • Scottish Cancer Trials Breast Group and ICRF Breast Unit, Guy's Hospital, London.
    • (1993) Lancet , vol.341 , pp. 1293-1298
  • 76
    • 0029903614 scopus 로고    scopus 로고
    • Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
    • Swedish Breast Cancer Cooperative Group.
    • (1996) J Natl Cancer Inst , vol.88 , pp. 1543-1549


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.